Recombinant Bacillus licheniformis Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] (glmS), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If a specific tag type is required, please inform us; we will prioritize its development.
Synonyms
glmS; BLi00204; BL02704Glutamine--fructose-6-phosphate aminotransferase [isomerizing]; EC 2.6.1.16; D-fructose-6-phosphate amidotransferase; GFAT; Glucosamine-6-phosphate synthase; Hexosephosphate aminotransferase; L-glutamine--D-fructose-6-phosphate amidotransferase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Bacillus licheniformis (strain ATCC 14580 / DSM 13 / JCM 2505 / NBRC 12200 / NCIMB 9375 / NRRL NRS-1264 / Gibson 46)
Target Names
glmS
Uniprot No.

Target Background

Function
This enzyme catalyzes the initial step in hexosamine metabolism, converting fructose-6-phosphate to glucosamine-6-phosphate using glutamine as the nitrogen source.
Database Links
Subcellular Location
Cytoplasm.

Q&A

Fundamental Characteristics of glmS in Bacillus licheniformis

Q: What is Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] (glmS) and what is its functional significance in Bacillus licheniformis?

A: Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] (glmS) is a critical enzyme in bacterial cell wall biosynthesis that catalyzes the conversion of fructose-6-phosphate to glucosamine-6-phosphate, utilizing glutamine as an amine donor. In Bacillus licheniformis, this enzyme plays an essential role in peptidoglycan synthesis, which forms the structural foundation of the bacterial cell wall. The enzyme functions at the intersection of carbon and nitrogen metabolism, making it vital for bacterial growth and survival, especially under varying environmental conditions. In B. licheniformis specifically, glmS activity may contribute to the organism's notable stress resistance, including its ability to withstand osmotic pressure up to 1M NaCl as part of its intermediate degree of osmotic stress resistance . The enzyme represents an important target for understanding bacterial metabolism and potentially for antimicrobial development.

Q: How does the cellular localization and regulation of glmS influence its function in B. licheniformis?

A: In B. licheniformis, glmS is predominantly a cytoplasmic enzyme whose expression and activity are tightly regulated in response to environmental conditions. The enzyme's expression appears to be modulated by several regulatory mechanisms, including transcriptional control through specific promoters that respond to environmental signals. This regulation is particularly important for B. licheniformis as it navigates diverse ecological niches and industrial environments. B. licheniformis employs various promoter systems—including constitutive, quorum sensing, and inducible promoters—which likely play roles in controlling glmS expression under different conditions . The enzyme's activity is also potentially influenced by osmotic stress conditions, as B. licheniformis demonstrates significant transcriptional and proteomic changes under high salinity. Since glmS is involved in cell wall synthesis, its regulation likely interfaces with the organism's stress response systems to maintain cell integrity under challenging environmental conditions, contributing to the bacterium's industrial utility and ecological adaptability.

Expression and Production Considerations

Q: What expression systems are most effective for producing recombinant B. licheniformis glmS?

A: Several expression systems have proven effective for producing recombinant B. licheniformis glmS, with B. licheniformis itself emerging as a particularly advantageous host. B. licheniformis has gained recognition as an exceptional expression platform in biomanufacturing due to its capacity to produce high-value proteins and enzymes . When using B. licheniformis as the expression host for its own glmS, researchers can benefit from homologous expression advantages, including appropriate post-translational modifications and native-like folding. Effective expression requires careful selection of promoters, with recent advancements expanding the toolbox to include constitutive promoters for consistent expression, quorum sensing promoters for density-dependent production, and inducible promoters for controlled expression . For example, the rhamnose-inducible promoter system (PrhaB) has shown promising results for controlled expression in B. licheniformis, with activity positively correlating with rhamnose concentration (0-20 g/L) . Other potential expression hosts include E. coli systems, which may require codon optimization but offer ease of genetic manipulation and well-established purification protocols.

Q: What purification challenges are specific to recombinant B. licheniformis glmS compared to similar enzymes from other sources?

A: Purification of recombinant B. licheniformis glmS presents several unique challenges stemming from the organism's physiological characteristics. First, B. licheniformis secretes numerous proteases that can degrade the target protein during extraction and purification processes. Modern expression strains have been developed with several protease genes inactivated to address this issue, similar to the modified strains used for glutaminase production . Second, the partial nature of some recombinant glmS preparations may create heterogeneity in the protein population, complicating purification and potentially affecting activity assessments. Third, B. licheniformis has distinct cell wall characteristics that can influence cell lysis efficiency and protein release. Researchers typically employ a multi-step purification strategy involving initial clarification steps (centrifugation, filtration), followed by chromatographic techniques (ion exchange, hydrophobic interaction, and affinity chromatography if the recombinant protein contains an affinity tag). Finally, B. licheniformis' ability to form endospores under stress conditions can complicate biomass processing and necessitates careful culture condition control to maintain cells in the vegetative state during production phases.

Structural and Functional Characteristics

Q: How does the partial recombinant B. licheniformis glmS differ functionally from the full-length protein, and what experimental approaches best characterize these differences?

A: The partial recombinant B. licheniformis glmS protein likely exhibits distinct functional differences from its full-length counterpart, primarily in domains related to substrate binding, catalytic efficiency, and regulatory responses. Truncation may remove regulatory regions while preserving the core catalytic domain, potentially resulting in altered enzyme kinetics or substrate specificity profiles. To characterize these differences comprehensively, researchers should employ a multi-faceted experimental approach. Steady-state kinetic analysis comparing substrate affinity (Km), catalytic efficiency (kcat/Km), and reaction velocity (Vmax) between partial and full-length variants provides fundamental performance metrics. Structural studies using X-ray crystallography or cryo-EM can reveal conformational differences affecting active site architecture. Thermal shift assays and circular dichroism spectroscopy help assess stability differences, while hydrogen-deuterium exchange mass spectrometry can map dynamic regions differently affected in the partial protein. Additionally, in silico molecular dynamics simulations can predict how truncation influences protein motion and substrate interactions. These approaches collectively generate a comprehensive comparison table of functional parameters between full-length and partial glmS variants, establishing structure-function relationships critical for enzyme engineering applications.

Q: What is the relationship between B. licheniformis glmS activity and the organism's stress response systems, particularly under osmotic stress conditions?

A: B. licheniformis glmS likely shares intricate connections with the organism's stress response systems, particularly during osmotic challenges when cell wall integrity becomes critically important. When B. licheniformis experiences sudden osmotic upshift (such as exposure to 1M NaCl), it activates a multi-faceted stress response involving transcriptional reprogramming and metabolic adjustments . The bacterium's remarkable ability to withstand salt concentrations up to 1M NaCl before experiencing growth inhibition suggests coordinated regulation of cell envelope biosynthesis enzymes, including glmS . The relationship likely involves multiple regulatory layers, including transcriptional control through SigB-dependent general stress response pathways activated during osmotic stress . Furthermore, metabolic redirection during osmotic stress may affect glutamine availability, the critical amine donor for glmS reaction, thus connecting osmoprotectant production with cell wall synthesis. Experimentally, this relationship could be explored through transcriptomic and proteomic analyses comparing glmS expression levels under various osmotic conditions, alongside metabolic flux analysis to trace nitrogen transfer from glutamine to cell wall precursors versus osmoprotectant synthesis pathways. Understanding this relationship has implications for optimizing recombinant protein production, as osmotic control might be leveraged to coordinate cell growth with protein expression.

Biotechnological Applications and Optimization

Q: How can promoter engineering strategies enhance the expression of recombinant B. licheniformis glmS, and what experimental design would systematically identify optimal promoter elements?

A: Promoter engineering represents a powerful approach for enhancing recombinant B. licheniformis glmS expression by fine-tuning transcriptional regulation. Recent advancements in B. licheniformis promoter characterization have revealed multiple promoter types with distinct regulatory profiles that can be strategically employed or modified for optimized expression . A comprehensive experimental design for identifying optimal promoter elements would begin with a library construction phase, systematically generating variants of constitutive promoters with modified -35 and -10 regions, spacer sequences, and upstream elements. For inducible control, the rhamnose-inducible promoter system could be particularly valuable, as it has demonstrated concentration-dependent activity in B. licheniformis, with increased activity correlating with rhamnose concentrations of 0-20 g/L . The experimental pipeline should include multiplex promoter testing using reporter systems (e.g., fluorescent proteins or luciferase) to rapidly screen strength and induction characteristics, followed by quantitative RT-PCR to verify transcription levels of promising candidates. Advanced approaches might incorporate hybrid promoter engineering, combining the most effective elements from multiple promoter types, or transcription factor-based inducible promoter engineering to create tightly regulated expression systems. Final validation would measure actual glmS production levels under different growth phases and environmental conditions.

Q: What are the current limitations in crystallizing recombinant B. licheniformis glmS for structural studies, and how might these be overcome through protein engineering approaches?

A: Crystallization of recombinant B. licheniformis glmS faces several significant challenges that limit structural elucidation. These include inherent flexibility in protein domains, heterogeneity in post-translational modifications, potential oligomeric state variability, and surface properties unfavorable for crystal lattice formation. The partial nature of some recombinant preparations introduces additional complexity through potential structural instability or exposed hydrophobic regions . A systematic protein engineering approach can address these limitations through several complementary strategies. Surface entropy reduction (SER) can replace surface-exposed flexible side chains (typically lysine and glutamate clusters) with alanine to promote crystal contacts. Strategic introduction of disulfide bridges might stabilize flexible regions without compromising catalytic activity. Targeted glycosylation site removal eliminates heterogeneity from variable glycosylation. Domain truncation approaches based on bioinformatic prediction and limited proteolysis can identify stable core domains with enhanced crystallizability. Fusion protein strategies incorporating well-crystallizing protein tags (T4 lysozyme, BRIL, or rubredoxin) at internal loops can provide crystal contact points. Implementation requires an iterative pipeline of variant generation, expression testing, thermal stability screening, and small-scale crystallization trials, with successful constructs advancing to comprehensive crystallization screening and optimization protocols.

Expression and Purification Protocols

Q: What optimized protocol yields maximum functional recombinant B. licheniformis glmS expression while minimizing degradation and maintaining enzyme activity?

A: An optimized protocol for maximizing functional recombinant B. licheniformis glmS expression begins with careful strain selection. Protease-deficient B. licheniformis strains are preferred expression hosts, as they mitigate degradation concerns similar to those addressed in engineered strains for glutaminase production, where multiple protease genes were inactivated . For expression vector design, the rhamnose-inducible promoter system offers tight regulation and concentration-dependent expression response, with optimal induction at 20 g/L rhamnose . Culture conditions should be precisely controlled, maintaining 37°C and pH 7.0-7.5 in a rich medium supplemented with 1% glucose during the growth phase, followed by induction at mid-log phase (OD600 of 0.6-0.8). Critically, cells should be harvested at early stationary phase to prevent sporulation, which can complicate downstream processing . Cell disruption is best accomplished through enzymatic cell wall digestion combined with gentle mechanical lysis to preserve enzyme activity. The purification workflow should employ IMAC (immobilized metal affinity chromatography) if the construct includes a histidine tag, followed by ion-exchange chromatography and gel filtration. Throughout purification, maintaining buffer conditions mimicking the cytoplasmic environment of B. licheniformis (including compatible solutes like proline) helps preserve native conformation and activity . Quality assessment should include SDS-PAGE, Western blotting, activity assays, and thermal shift assays to verify identity, purity, functionality, and stability.

Analytical Methods and Activity Assays

Q: What spectrophotometric assay provides the most reliable quantification of recombinant B. licheniformis glmS activity, and what controls are essential for method validation?

A: A highly reliable spectrophotometric assay for quantifying recombinant B. licheniformis glmS activity employs a coupled enzyme system that monitors the conversion of fructose-6-phosphate to glucosamine-6-phosphate by measuring glutamate formation. The coupled reaction utilizes glutamate dehydrogenase to convert the produced glutamate to α-ketoglutarate while reducing NAD+ to NADH, which can be measured by absorbance increase at 340 nm. This provides a continuous, real-time measurement of glmS activity that can be readily standardized. Essential controls for proper method validation include enzyme-free blanks to account for non-enzymatic reactions, heat-inactivated enzyme controls to establish baseline signals, and substrate-free controls to measure background NADH production. Complete method validation requires establishing linearity ranges for both enzyme concentration and reaction time, determining lower limits of detection and quantification, and assessing intra-day and inter-day precision. Standard reaction conditions should maintain physiologically relevant parameters (pH 7.5, 37°C) while systematically varying substrate concentrations to determine kinetic parameters. The assay buffer composition should include appropriate osmolytes that mimic B. licheniformis cytoplasmic conditions, potentially incorporating compatible solutes like proline that are naturally accumulated by B. licheniformis under stress conditions . This method enables the construction of a comprehensive kinetic profile table comparing enzyme variants or preparations under standardized conditions.

Table 1: Standardized Kinetic Parameters for Recombinant B. licheniformis glmS Activity Assessment

ParameterMeasurement ConditionExpected RangeValidation Method
Km (Fructose-6-P)pH 7.5, 37°C, 5 mM glutamine0.2-1.0 mMLineweaver-Burk plot
Km (Glutamine)pH 7.5, 37°C, 2 mM F6P0.5-2.0 mMLineweaver-Burk plot
VmaxpH 7.5, 37°C, saturating substratesVariable by preparationMichaelis-Menten kinetics
kcatpH 7.5, 37°C, saturating substrates1-10 s⁻¹Enzyme concentration series
pH optimum25°C, saturating substratespH 7.0-8.0Activity vs. pH curve
Temperature optimumpH 7.5, saturating substrates35-45°CActivity vs. temperature curve
Salt tolerancepH 7.5, 37°C, varying NaClActive up to 0.5M NaClActivity retention percentage

Site-Directed Mutagenesis Applications

Q: How can structure-guided site-directed mutagenesis be employed to enhance the catalytic efficiency of recombinant B. licheniformis glmS for biotechnological applications?

A: Structure-guided site-directed mutagenesis offers a powerful approach for enhancing the catalytic efficiency of recombinant B. licheniformis glmS by systematically modifying specific amino acid residues based on structural insights and evolutionary conservation patterns. The implementation begins with comprehensive sequence alignment across bacterial glmS enzymes, identifying both highly conserved catalytic residues and variable regions that might confer species-specific properties. Homology modeling based on existing crystal structures from related organisms provides the structural framework for identifying target residues in three critical categories: active site residues for substrate binding optimization, second-shell residues that influence active site geometry, and surface residues affecting stability and solubility. Mutations at the active site might focus on enhancing substrate recognition or improving transition state stabilization, while second-shell modifications often target hydrogen bonding networks and electrostatic interactions that position catalytic residues optimally. Surface modifications can address stability under industrial conditions by introducing salt bridges or removing hydrophobic patches. The experimental design should include high-throughput screening approaches to assess thousands of variants efficiently, employing the standardized activity assay described previously. Promising mutations can be combined through iterative rounds of mutagenesis, with each generation evaluated for additive or synergistic effects. This approach might leverage known stress response adaptations of B. licheniformis, potentially incorporating features that contribute to the organism's notable resilience under challenging conditions .

Osmotic Stress Response Mechanisms

Q: How does recombinant B. licheniformis glmS activity correlate with the organism's osmoadaptation strategies, and what experimental approaches can elucidate this relationship?

A: Recombinant B. licheniformis glmS activity likely exhibits significant correlations with the organism's sophisticated osmoadaptation strategies through connections between cell wall biosynthesis and osmoprotectant accumulation pathways. B. licheniformis demonstrates remarkable osmotic stress resistance, tolerating salt concentrations up to 1M NaCl before experiencing substantial growth inhibition . This adaptation involves coordinated systems for synthesizing or importing compatible solutes, particularly proline as the dominant osmoprotectant and glycine betaine through choline oxidation under high-salinity conditions . The glmS enzyme's role in cell wall precursor synthesis positions it at a critical intersection, where nitrogen metabolism must be balanced between structural components and stress protectants. To elucidate this relationship experimentally, researchers could employ a multi-faceted approach. Transcriptomic and proteomic profiling comparing glmS expression levels with osmoadaptation genes across salt concentration gradients would establish correlation patterns. Metabolic flux analysis using isotope-labeled precursors could trace nitrogen distribution between cell wall synthesis and compatible solute production pathways under varying osmotic conditions. Genetic approaches, including glmS conditional expression strains, would allow observation of how altered glmS levels impact osmotic tolerance, potentially revealing regulatory connections. Growth phenotyping comparing wild-type and modified strains across osmotic gradients would provide functional evidence of interconnections between these systems and potentially identify optimal conditions for recombinant enzyme production.

Biotechnological Implications

Q: How might understanding the stress-responsive regulation of glmS in B. licheniformis inform optimized production strategies for recombinant proteins in industrial settings?

A: Understanding the stress-responsive regulation of glmS in B. licheniformis can substantially inform optimized production strategies for recombinant proteins by uncovering fundamental connections between cellular physiology and protein expression machinery. B. licheniformis has been recognized as an exceptional expression platform in biomanufacturing due to its ability to produce high-value products and adapt to industrial conditions . The bacterium's remarkable ability to withstand salt concentrations up to 1M NaCl while maintaining metabolic activity demonstrates sophisticated regulatory systems that could be leveraged for enhanced recombinant protein production . Practically, this knowledge can be applied by manipulating osmotic conditions during fermentation to synchronize cell growth with protein production phases. Controlled osmotic upshift might trigger specific stress response pathways that enhance protein stability and secretion efficiency through altered cell envelope properties. Additionally, insights into how glmS regulation intersects with the SigB-controlled general stress response could inform the development of engineered promoter systems that couple recombinant protein expression to cellular stress adaptation mechanisms . The expanding promoter toolbox for B. licheniformis, including advances in hybrid promoter engineering and transcription factor-based inducible promoter systems, provides versatile genetic tools for implementing these strategies . Furthermore, understanding the cell's compensatory mechanisms for balancing resources between structural components and stress protection could guide media composition optimization, particularly for nitrogen sources that feed into both glmS substrate pathways and osmoprotectant synthesis.

Q: What emerging technologies might revolutionize our understanding and application of recombinant B. licheniformis glmS in the next decade?

A: Emerging technologies poised to revolutionize our understanding and application of recombinant B. licheniformis glmS span multiple scientific domains and offer unprecedented opportunities for fundamental discoveries and biotechnological advances. CRISPR-Cas systems optimized for B. licheniformis will enable precise genome editing for creating designer strains with enhanced glmS expression or modified regulatory circuits. Single-cell multi-omics technologies will reveal cell-to-cell variability in glmS expression and activity, potentially uncovering previously unrecognized subpopulation behaviors under stress conditions. Advanced structural biology techniques, including time-resolved cryo-EM and X-ray free-electron laser crystallography, will capture dynamic conformational changes during catalysis, providing insights for rational enzyme engineering. Synthetic biology approaches will incorporate glmS into artificial metabolic pathways for novel bioconversion processes, potentially utilizing the enzyme's isomerizing capabilities for producing high-value compounds. Machine learning algorithms trained on comprehensive datasets of enzyme variants will accelerate directed evolution efforts by predicting beneficial mutations. Microfluidic cultivation systems will enable high-throughput screening of glmS variants under precisely controlled microenvironments mimicking industrial conditions. Additionally, innovations in continuous bioprocessing might leverage understanding of B. licheniformis stress physiology to develop robust extended-duration production systems with stable recombinant protein expression . These technologies collectively promise to elevate recombinant B. licheniformis glmS from a model enzyme to a versatile biocatalytic platform with expanded applications in pharmaceutical, chemical, and material sciences.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.